A scoping review of costing methodologies used to assess interventions for underserved pregnant people and new parents.

BACKGROUND: Lack of evidence about the long-term economic benefits of interventions targeting underserved perinatal populations can hamper decision making regarding funding. To optimize the quality of future research, we examined what methods and costs have been used to assess the value of interventions targeting pregnant people and/or new parents who have poor access to healthcare. METHODS: We conducted a scoping review using methods described by Arksey and O'Malley. We conducted systematic searches in eight databases and web-searches for grey literature. Two researchers independently screened results to determine eligibility for inclusion. We included economic evaluations and cost analyses of interventions targeting pregnant people and/or new parents from underserved populations in twenty high income countries. We extracted and tabulated data from included publications regarding the study setting, population, intervention, study methods, types of costs included, and data sources for costs. RESULTS: Final searches were completed in May 2024. We identified 103 eligible publications describing a range of interventions, most commonly home visiting programs (n = 19), smoking cessation interventions (n = 19), prenatal care (n = 11), perinatal mental health interventions (n = 11), and substance use treatment (n = 10), serving 36 distinct underserved populations. A quarter of the publications (n = 25) reported cost analyses only, while 77 were economic evaluations. Most publications (n = 82) considered health care costs, 45 considered other societal costs, and 14 considered only program costs. Only a third (n = 36) of the 103 included studies considered long-term costs that occurred more than one year after the birth (for interventions occurring only in pregnancy) or after the end of the intervention. CONCLUSIONS: A broad range of interventions targeting pregnant people and/or new parents from underserved populations have the potential to reduce health inequities in their offspring. Economic evaluations of such interventions are often at risk of underestimating the long-term benefits of these interventions because they do not consider downstream societal costs. Our consolidated list of downstream and long-term costs from existing research can inform future economic analyses of interventions targeting poorly served pregnant people and new parents. Comprehensively quantifying the downstream and long-term benefits of such interventions is needed to inform decision making that will improve health equity.

Cost-utility analysis of prenatal supplementation with long-chain n-3 fatty acids to reduce the incidence of wheezing and asthma in neonates.

INTRODUCTION: Recent evidence indicates that Maternal Supplementation with Long-Chain n-3 Fatty Acids During Pregnancy Substantially Mitigates Offspring's Asthma. Adding information regarding its cost-utility will undoubtedly allow its adoption, or not, in clinical practice guidelines. This research aimed to determine the cost-utility of LCPUFA supplementation in the third trimester of pregnancy to reduce the risk of wheezing and asthma in infants in Colombia. METHODS: A Markov model was formulated to estimate the cost and quality-adjusted life-years (QALYs) attributed to individuals with severe asthma in Colombia, with a time horizon of five years and a cycle length of two weeks. Probabilistic sensitivity analysis and a value of information (VOI) analysis were conducted to evaluate the uncertainties in the case base. Cost-utility was assessed at a willingness-to-pay (WTP) value of US$5180. All costs were adjusted to 2021 with a 5% annual discounting rate for cost and QALYs. RESULTS: The mean incremental cost of LCPUFA supplementation versus no supplementation was US-43.65. The mean incremental benefit of LCPUFA supplementation versus no supplementation was 0.074 QALY. The incremental cost-utility ratio was estimated at US$590.68 per QALY. The outcomes derived from our primary analysis remained robust when subjected to variations in all underlying assumptions and parameter values. CONCLUSION: Supplementation strategy supplementation with long-chain n-3 fatty acids during pregnancy is cost-effective in reducing the risk of developing asthma during childhood in Colombia.

The costs and benefits of scaling up interventions to prevent poor birth outcomes in low-income and middle-income countries: a modelling study.

BACKGROUND: We estimated the benefits and costs of a set of preventive interventions that could be delivered during antenatal care to prevent poor birth outcomes, including small-for-gestational-age and preterm births. We built on the assumptions and analyses underlying the Lancet Series on small vulnerable newborns (SVNs) and extended that work by incorporating more recent data, focusing only on the subset of preventive interventions, and examining a broader range of effects. A primary aim of the study was to provide a framework that decision makers could use to design programmes for women and children. METHODS: The analyses used the Lives Saved Tool (LiST) to estimate the effects and costs of scaling up the 11 preventive interventions identified in the SVN Series to improve birth outcomes. We used LiST estimates of effects and costs to estimate benefit-cost ratios (BCRs) for two intervention packages (one with interventions proven to improve birth outcomes and one with proven interventions plus interventions with potential to improve birth outcomes) and for the individual interventions in these packages for 80 low-income and middle-income countries (LMICs). FINDINGS: Both packages of interventions had BCRs more than 1, with a proven package BCR of 7·3 (IQR 5·3-9·1) and a proven plus potential package BCR of 5·8 (4·4-6·9). We found that in all cases the individual interventions had BCRs more than 1, there was a wide range of BCR values for the different interventions, and the BCR varied depending on package and country. INTERPRETATION: The analyses presented in this Article provide evidence that there are preventive interventions that, if scaled up in LMICs, could have a large effect on child health and provide benefits that greatly exceed the costs. FUNDING: Global Affairs Canada.

Cost-effectiveness of antenatal fetal surveillance for medication-treated gestational diabetes.

OBJECTIVE: To evaluate the relative cost-effectiveness of starting antenatal fetal surveillance at 32 vs. 36 weeks, in medication-treated gestational diabetes. METHODS: We performed a 2017-2022 retrospective cohort study of patients with medication-treated GDM who underwent BPPs. Patients diagnosed before 24 weeks, those delivered before 32 weeks, and those without BPPs or delivery data were excluded. Demographic and outcome data were abstracted by chart review. We performed a cost-effectiveness analysis regarding two outcomes: stillbirth, and decision to alter delivery timing following abnormal BPPs. RESULTS: A total of 652 pregnancies were included. Patients were 49% privately insured, 25% publicly insured, and 26% uninsured. We assumed that each BPP cost $145. In total, 1,284 BPPs occurred after 36 weeks, costing $186,180, and 2,041 BPPs occurred between 32 and 36 weeks, costing an additional $295,945. Twelve deliveries resulted from abnormal BPPs, all after 36 weeks. No stillbirths occurred. The cost to attempt to avoid one stillbirth was $40,177 across all patients. In our sample, starting surveillance at 36 weeks would have theoretically avoided all stillbirths, with cost savings per avoided stillbirth of $51,572 for privately insured patients, $14,123 for publicly insured patients, and $17,799 for patients without insurance. CONCLUSION: Based on this population with no stillbirths and no BPPs dictating delivery before 36 weeks, surveillance after 36 weeks may be safe and cost-effective. Our findings reflect opportunities for shared decision making and potential practice change, with greatest impact for low socioeconomic status patients and those without insurance.

Cost-effectiveness of a complex continuum of care intervention targeting women and children: protocol for an economic evaluation of the Bukhali trial in South Africa.

INTRODUCTION: As nearly two-thirds of women presenting at their first antenatal visit are either overweight or obese in urban South Africa, the preconception period is an opportunity to optimise health and offset transgenerational risk of both obesity and non-communicable diseases. This protocol describes the planned economic evaluation of an individually randomised controlled trial of a complex continuum of care intervention targeting women and children in Soweto, South Africa (Bukhali trial). METHODS AND ANALYSIS: The economic evaluation of the Bukhali trial will be conducted as a within-trial analysis from both provider and societal perspectives. Incremental costs and health outcomes of the continuum of care intervention will be compared with standard care. The economic impact on implementing agencies (programme costs), healthcare providers, participants and their households will be estimated. Incremental cost-effectiveness ratios (ICERs) will be calculated in terms of cost per case of child adiposity at age years averted. Additionally, ICERs will also be reported in terms of cost per quality-adjusted life year gained. If Bukhali demonstrates effectiveness, we will employ a decision analytical model to examine the cost-effectiveness of the intervention over a child's lifetime. A Markov model will be used to estimate long-term health benefits, healthcare costs and cost-effectiveness. Probabilistic sensitivity analyses will be conducted to explore uncertainty and ensure robust results. An analysis will be conducted to assess the equity impact of the intervention, by comparing intervention impact within quintiles of socioeconomic status. ETHICS AND DISSEMINATION: The Bukhali trial economic evaluation has ethical approval from the Human Ethics Research Committee of the University of the Witwatersrand, Johannesburg, South Africa (M240162). The results of the economic evaluation will be disseminated in a peer-reviewed journal and presented at a relevant international conference. TRIAL REGISTRATION NUMBER: Pan African Clinical Trials Registry (PACTR201903750173871; https://pactr.samrc.ac.za).

Antenatal cardiotocography in primary midwife-led care: a budget impact analysis.

OBJECTIVES: In many countries, the healthcare sector is dealing with important challenges such as increased demand for healthcare services, capacity problems in hospitals and rising healthcare costs. Therefore, one of the aims of the Dutch government is to move care from in-hospital to out-of-hospital care settings. An example of an innovation where care is moved from a more specialised setting to a less specialised setting is the performance of an antenatal cardiotocography (aCTG) in primary midwife-led care. The aim of this study was to assess the budget impact of implementing aCTG for healthy pregnant women in midwife-led care compared with usual obstetrician-led care in the Netherlands. METHODS: A budget impact analysis was conducted to estimate the actual costs and reimbursement of aCTG performed in midwife-led care and obstetrician-led care (ie, base-case analysis) from the Dutch healthcare perspective. Epidemiological and healthcare utilisation data describing both care pathways were obtained from a prospective cohort, survey and national databases. Different implementation rates of aCTG in midwife-led care were explored. A probabilistic sensitivity analysis was conducted to estimate the uncertainty surrounding the budget impact estimates. RESULTS: Shifting aCTG from obstetrician-led care to midwife-led-care would increase actual costs with €311 763 (97.5% CI €188 574 to €426 072) and €1 247 052 (97.5% CI €754 296 to €1 704 290) for implementation rates of 25% and 100%, respectively, while it would decrease reimbursement with -€7 538 335 (97.5% CI -€10 302 306 to -€4 559 661) and -€30 153 342 (97.5% CI -€41 209 225 to -€18 238 645) for implementation rates of 25% and 100%, respectively. The sensitivity analysis results were consistent with those of the main analysis. CONCLUSIONS: From the Dutch healthcare perspective, we estimated that implementing aCTG in midwife-led care may increase the associated actual costs. At the same time, it might lower the healthcare reimbursement.

Community-based strategies to increase coverage of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine in sub-Saharan Africa: a systematic review, meta-analysis, meta-ethnography, and economic assessment.

BACKGROUND: Community-based approaches might increase uptake of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine (IPTp-SP). We assessed the effects of community-based approaches on IPTp-SP and antenatal care coverage, and barriers and facilitators to implementation in sub-Saharan Africa. METHODS: We did a systematic review, meta-analysis, meta-ethnography, and economic assessment. We searched the WHO International Clinical Trials Registry Platform, PubMed, the Malaria in Pregnancy Library database, Medline, Global Health and Global Health Archives, and the Cochrane Library for trials, mixed-methods, qualitative, and cost-effectiveness studies of community health worker promotion of antenatal care, IPTp-SP delivery, or both, with no language restrictions, published before March 21, 2024. Information on interventions, number of IPTp-SP doses, antenatal care visits, and barriers and facilitators were extracted. We did a meta-analysis (random effects) comparing effects on two or more or three or more IPTp-SP doses and one or more or four or more antenatal care visits. We followed Noblit and Hare's method of meta-ethnography to synthesise qualitative findings, using reciprocal translation and line-of-argument synthesis. We developed a theory for increased community IPTp-SP uptake. We also summarised cost and cost-effectiveness studies. This study is registered with PROSPERO, CRD42022364114. FINDINGS: Of 4753 records screened, we included 23 (0·5%) reporting on 15 studies. Community health worker involvement was associated with an increase in two or more IPTp-SP doses (pooled risk ratio 1·48, [95% CI 1·24-1·75]; 12 sub-studies; I2 94·7%) and three or more IPTp-SP doses (1·73 [1·19-2·50]; ten sub-studies, I2 97·5%), with no decrease in four or more antenatal care visits (1·17 [1·00-1·36]; 13 sub-studies; I2 90·3%). Cluster-randomised controlled trials showed a lower increase in coverage of three or more IPTp-SP doses (1·08 [1·00-1·16]; I2 0·0%; six studies) compared with before-and-after studies (2·86 [1·29-6·33]; I2 98·9%; four studies; subgroup analysis p=0·019). Barriers to community health worker delivery of IPTp-SP included women's fear of side-effects, lack of knowledge, lack of trust in community health workers, and sociocultural factors. Community sensitisation, engagement of husbands, pre-established community health worker networks, and trained and supported community health workers facilitated IPTp-SP delivery by community health workers. Incremental cost-effectiveness ratios ranged from $1·1 to $543 per disability-adjusted life-year averted. INTERPRETATION: Community-based approaches increased IPTp-SP coverage and might have a positive effect on the number of antenatal care visits in addition to being cost-effective, although we found high heterogeneity among studies. Community sensitisation and engagement in addition to established, trained, and supported community health workers can facilitate acceptability, delivery, and uptake of IPTp-SP delivered by community health workers. FUNDING: EDCTP-2 supported by the European Union. TRANSLATION: For the French translation of the abstract see Supplementary Materials section.

Costs of integrating hepatitis B screening and antiviral prophylaxis into routine antenatal care in Burkina Faso: Treat all versus targeted strategies.

OBJECTIVE: Economic feasibility of eliminating mother-to-child transmission (MTCT) of hepatitis B virus (HBV) in highly endemic African countries remains uncertain. Prevention of MTCT (PMTCT) involves screening pregnant women for hepatitis B surface antigen (HBsAg), identifying those with high viral loads or hepatitis B e antigen (HBeAg), and administering tenofovir prophylaxis to high-risk women. We estimated the costs of integrating PMTCT services into antenatal care in Burkina Faso, based on four different strategies to select women for tenofovir prophylaxis: (1) HBV DNA (≥200 000 IU/mL), (2) HBeAg, (3) hepatitis B core-related antigen rapid diagnostic test (HBcrAg-RDT) and (4) all HBsAg-positive women. METHODS: Using a micro-costing approach, we estimated the incremental economic cost of integrating each strategy into routine antenatal care in 2024, compared to neonatal vaccination alone. Sensitivity analyses explored variations in prevalence, service coverage, test and tenofovir prices. RESULTS: HBcrAg-RDT strategy was the least expensive, with a total economic cost of US$3959689, compared to HBV DNA (US$6128875), HBeAg (US$4135233), and treat-all (US$4141206). The cost per pregnant woman receiving tenofovir prophylaxis varied from US$61.88 (Treat-all) to US$1071.05 (HBV DNA). The Treat-All strategy had the lowest marginal cost due to a higher number of women on tenofovir (66928) compared to HBV DNA (5722), HBeAg (10020), and HBcrAg-RDT (7234). In sensitivity analyses, the treat-all strategy became less expensive when the tenofovir price decreased. CONCLUSION: HBcrAg-RDT minimizes resource use and costs, representing 0.61% of Burkina Faso's 2022 health budget. This study highlights the potential economic feasibility of these strategies and provides valuable resources for conducting cost-effectiveness analyses.

Costo-efectividad de la calidad del control prenatal con respecto al bajo peso al nacer en el Cauca / Antenatal control quality cost-effectiveness regarding low birth weight in Cauca

Antecedentes: El departamento del Cauca en Colombia es multiétnico, multicultural y biodiverso, también con grandes diferencias en bajo peso al nacer (BPN), mortalidad perinatal y mortalidad neonatal tardía entre municipios. Objetivo: Determinar la relación de costo-efectividad del control prenatal (CPN) cuando ha tenido buena calidad frente al que ha tenido calidad deficiente con respecto al BPN en el departamento del Cauca entre 2018 y 2020. Método: Evaluación económica con diseño epidemiológico de una cohorte histórica desde la perspectiva de la institución pagadora. Se calculó la razón incremental de costo-efectividad (RICE), análisis de sensibilidad e impacto presupuestal. Resultados: La incidencia de BPN fue del 8,3% (348/4182). La calidad deficiente en el CPN incrementó el riesgo de BPN (OR: 3,38; IC95%: 1,05-8,2) y la buena calidad tuvo una mejor relación de costo-efectividad (RICE: USD 2727,75), con posición dominante frente a la calidad deficiente (6,14 veces el PIB per cápita de ahorro) y con un impacto presupuestal de USD 2.904.392. Conclusiones: La buena calidad del CPN en el departamento del Cauca durante 2018-2020 fue costo-efectiva y dominante por ser de menor costo y mayor efectividad.

Background: The department of Cauca in Colombia is multiethnic, multicultural, and biodiverse, also with large differences in low birth weight (LBW), perinatal mortality, and late neonatal mortality among municipalities. Objective: To determine the cost-effectiveness relationship of antenatal care (ANC) when it has had good quality compared to that which has had poor quality with respect to low birth weight in the department of Cauca between 2018 and 2019. Method: Economic evaluation with epidemiological cohort design historical from the perspective of the payer institution. Incremental cost-effectiveness ratio (RICE), sensitivity analysis, and budgetary impact were calculated. Results: The incidence of LBW was 8.3% (348/4182). Poor quality in ANC increased the risk of LBW (OR: 3.38; CI95%: 1.05-8.2), good quality had a better cost-effectiveness ratio (RICE: USD 2727.75), with dominant position against poor quality (6.14 times the GDP/capita savings) with a budgetary impact of USD 2,904,392. Conclusions: The good quality of the ANC in the department of Cauca during 2018-2020 was cost-effective and dominant because it is lower cost and more effective.

Cost utility of penicillin use in primary care for the prevention of complications associated with syphilis / Custo-utilidade do uso da penicilina na atenção primária para a prevenção de complicações associadas à sífilis congênita

Introduction: Despite penicillin being the drug of choice for the treatment of syphilis, many pregnant women who test positive for syphilis do not receive the drug as recommended by the Ministry of Health, contributing to the increase in costs associated with congenital syphilis. Objective: This study aims to estimate the incremental cost-effectiveness ratio of administering at least one dose of 2.4 million IU of benzathine penicillin in the first trimester of pregnancy as soon as the result of a positive rapid treponemal test performed during antenatal care in primary care units of the Brazilian National Health System. Methods: An analytical model was proposed based on a decision tree. The perspective of the analysis was the one used in The Brazilian National Health System. The clinical outcomes were abortion, prematurity, neonatal death, stillbirth, and congenital syphilis, estimated in terms of disability-adjusted life-years. Only direct costs were considered. Deterministic and probabilistic sensitivity analyses were performed. Results: The model predicted that the most efficient strategy is the one that includes the administration of penicillin in primary care for cases of gestational syphilis. This strategy is more effective, although more costly. The cost per disability-adjusted life-years averted with the use of this strategy was estimated at R$49.79 (US$ 10.67). Conclusion: The prenatal strategy in primary care units that includes the administration of penicillin to pregnant women with syphilis during the first trimester of pregnancy has the greatest potential to be cost-effective.

Introdução: A despeito de a penicilina ser o medicamento de escolha para o tratamento da sífilis, muitas gestantes com teste positivo para sífilis não recebem o medicamento como recomendado pelo Ministério da Saúde, concorrendo para o aumento dos custos associados à sífilis congênita. Objetivo: Estimar a razão de custo-efetividade incremental da administração de pelo menos uma dose de 2,4 milhões de Unidades Internacionais de penicilina benzatina no primeiro trimestre de gravidez, tão logo se tenha o resultado de um teste rápido treponêmico positivo realizado na consulta pré-natal em unidades de atenção primária do Sistema Único de Saúde. Métodos: Um modelo analítico foi proposto a partir de uma árvore de decisão. A perspectiva da análise foi a do Sistema Único de Saúde. Os desfechos em saúde foram aborto, prematuridade, morte neonatal, natimorto e sífilis congênita, estimados em termos de anos de vida ajustados a incapacidades (disability-adjusted life-years). Apenas os custos diretos foram considerados. Análises de sensibilidade determinística e probabilística foram realizadas. Resultados: O modelo previu que a estratégia mais eficiente é aquela que inclui a administração da penicilina na atenção primária aos casos de sífilis gestacional. Embora essa estratégia possa representar maior custo, apresenta maior efetividade. O custo por disability-adjusted life-years evitado com o uso dessa estratégia foi estimado em R$49,79. Conclusão: A estratégia de pré-natal nas unidades de atenção primária que inclui a administração da penicilina em gestantes com sífilis ainda no primeiro trimestre de gestação é a que apresenta o maior potencial para ser custo-efetiva.

Impacto económico y sanitario del control prenatal en embarazadas afiliadas al régimen subsidiado en Colombia durante 2014 / Economic and health impact of prenatal care in pregnant women with public health insurance in Colombia during 2014

Resumen: Objetivo: Analizar el impacto sanitario y económico del control prenatal (CPN) en mujeres de hogares pobres. Material y métodos: Se tomó una muestra aleatoria de 9 244 mujeres embarazadas (población= 25 000). Se estimó la incidencia de mortalidad materna, los costos directos de atención y la diferencia de medias y proporciones. Los costos fueron estimados en dólares americanos (USD) de 2014, con perspectiva del tercer pagador. Resultados: El 75% de las mujeres viven en zonas urbanas. La media de edad fue de 23 años (IC95%: 23.5-23.8). El 87.5% asistió al menos a una cita de CPN. El costo medio de partos con CPN fue de USD$ 609.1 (IC95%: 581-632.7). Sin CPN fue de USD $857.8 (IC95%: 774.7-923.8). Los costos se incrementan 32% (IC95% 27.1-41) sin CPN. Conclusión: El CPN es una intervención eficiente y efectiva para la gestión del riesgo de la salud materna.

Abstract: Objective: To estimate health care costs of live births and the impact of prenatal care visit (PCV) in women from poor households. Materials and methods: A randomized sample of 9 244 pregnant women (out of total= 25 000). Mean differences and proportions were calculated to compare results in both groups of women. The costs were estimated in American Dollars (USD) 2014, from the payer’s perspective. Results: 75% of women live in urban areas. The mean age was 23 years old (CI95% 23.5-23.8). The average cost with PCV was USD 609.1 (CI95%: 581-632.7) and without PCV was USD 857.8 (CI95%: 774.7-923.8) and 87% of women attended at least one PCV. The health care costs increased in 32% (CI95% 27.1-41) in women who did not attended PCV. Conclusion: The PCV is an efficient and effective intervention for managing the risk of maternal health.

¿El aseguramiento público en salud mejora la atención en los servicios? El caso de la atención prenatal en adolescentes en México / Does public health insurance improve health care? The case of prenatal care for adolescents in Mexico

Resumen: Objetivo: Comprobar la asociación entre el aseguramiento público en salud y la atención prenatal adecuada en mujeres adolescentes. Material y métodos: Análisis transversal de datos de 3 978 mujeres (N=4 522 296) que reportaron embarazo en la adolescencia (12-19 años), derivados de las Encuestas Nacional de Salud 2000 y de Salud y Nutrición 2006 y 2012. Mediante modelos de regresión logística se analizó oportunidad, frecuencia y contenido de la atención prenatal. Resultados: La probabilidad de recibir atención prenatal oportuna y frecuente aumentó de 0.60 (IC95%:0.56;0.64) en 2000 a 0.71 (IC95%:0.66;0.76) en 2012. En 2012 la probabilidad de recibir atención oportuna, frecuente y con contenido básico fue 0.54 (IC95%:0.49;0.58) siendo mayor en mujeres con Seguridad Social que en aquéllas afiliadas al Seguro Popular o sin aseguramiento. Conclusión: Contar con seguridad social incrementa la probabilidad de recibir atención prenatal adecuada en adolescentes en México.

Abstract: Objective: To test the association between public health insurance and adequate prenatal care among female adolescents in Mexico. Materials and methods: Cross-sectional study, using the National Health and Nutrition Survey 2000, 2006, and 2012.We included 3 978 (N=4 522 296) adolescent (12-19) women who reported a live birth.We used logistic regression models to test the association of insurance and adequate (timeliness, frequency and content) prenatal care. Results: The multivariable predicted probability of timely and frequent prenatal care improved over time, from 0.60 (IC95%:0.56;0.64) in 2000 to 0.71 (IC95%:0.66;0.76) in 2012. In 2012, the probability of adequate prenatal care was 0.54 (IC95%:0.49;0.58); women with Social Security had higher probability than women with Seguro Popular and without health insurance. Conclusion: Having Social Security is associated with receipt of adequate prenatal care among adolescents in Mexico.

Access to prenatal care: inequalities in a region with high maternal mortality in southeastern Brazil / Acesso ao pré-natal: desigualdades em região de alta mortalidade materna do sudeste brasileiro

Abstract Aim This article aims to evaluate access to prenatal care according to the dimensions of availability, affordability and acceptability in the SUS microregion of southeastern Brazil. Methods A cross-sectional study conducted in 2012-2013 that selected 742 postpartum women in seven hospitals in the region chosen for the research. The information was collected, processed and submitted to the chi-square test and the nonparametric Spearman’s test, with p-values less than 5% (p < 0.05). Results Although the SUS constitutionally guarantees universal access to health care, there are still inequalities between pregnant women from rural and urban areas in terms of the availability of health care and among families earning up to minimum wage and more than one minimum wage per month in terms of affordability; however, the acceptability of health care was equal, regardless of the modality of the health services. Conclusion The location, transport resources and financing of health services should be reorganised, and the training of health professionals should be enhanced to provide more equitable health care access to pregnant women.

Resumo Este artigo tem por objetivo avaliar o acesso à assistência pré-natal segundo as dimensões de disponibilidade, capacidade de pagar e aceitabilidade, no SUS de uma microrregião do sudeste brasileiro. Trata-se de um estudo seccional, realizado em 2012-2013, que selecionou 742 puérperas em sete maternidades da região escolhida para a pesquisa. As informações foram coletadas, processadas e submetidas ao teste Qui-quadrado e ao teste não paramétrico de Spearman, com p-valor menor que 5% (p < 0,05). Apesar de o SUS garantir constitucionalmente o acesso universal ao sistema de saúde, nota-se que ainda existem iniquidades entre as puérperas da zona rural e urbana quanto à disponibilidade e, entre as famílias que ganham até um salário mínimo e mais de um salário mínimo por mês, quando se relaciona à capacidade de pagar, porém a aceitabilidade revelou-se igual, independentemente da modalidade dos serviços de saúde. O local de moradia, os recursos de transporte e o financiamento dos serviços de saúde devem ser reorganizados, e a formação dos profissionais de saúde aprimorada, a fim de oferecer um acesso mais justo às gestantes.

Barreras y facilitadores para actividad física durante el embarazo y posparto en mujeres pobres de México / Barriers and facilitators for physical activity during pregnancy and postpartum in women living in poverty of Mexico

Objetivo. Explorar percepciones de proveedores de salud y beneficiarías del Programa Oportunidades sobre la práctica de actividad física durante el embarazo y posparto, e identificar características de la consejería sobre el tema en el primer nivel de atención en salud. Material y métodos. Estudio de métodos mixtos que forma parte de una intervención en nutrición del Programa Oportunidades. La información cualitativa se colectó por entrevista (50 mujeres; 34 proveedores de salud) y se obtuvo información cuantitativa a partir de un cuestionario (n=88 mujeres; n=64 proveedores; n=111 observaciones de consulta). Resultados. Se documentaron barreras a) individuales: falta de tiempo y de apoyo social; b) socioculturales: prejuicios de pares y familiares, y falta de instructores, y c) ambientales: falta de espacios físicos seguros y apropiados. 38% de las mujeres reporta haber recibido consejería sobre el tema versus 63.4% de proveedores que reportan haberla dado (p=0.002). Conclusiones. Urgen capacitación a proveedores y promoción de la actividad física que eliminen los prejuicios asociados al tema durante el embarazo y posparto.

Objective.To explore perceptions of healthcare providers and beneficiaries of Oportunidades program on physical activity during pregnancy and post-partum; and identify current reported practices related to counseling on physical activity in the primary healthcare services in Mexico. Materials and methods. A mixed methods approach was used which is part of a nutrition intervention of the Oportunidades program. Qualitative information was collected through interviews (50=women; 34=providers) and quantitative information was collected by questionnaires (n=88 women; n=64 provider; n=111 observations during consultation). Results. The main barriers were: a) individual (lack of time and social support to childcare); b) sociocultural (gender bias derived from peer groups or family and lack of instructors), and c) environmental (lack of safe and adequate physical places). Only 38% of beneficiary women reported having been counseled on physical activity vs 63.4% of providers who reported having counseled on physical activity (p=0.002). Conclusion. There is a need to train healthcare providers and to promote physical activity during pregnancy and post-partum for reducing associated biases.

Evaluación del seguimiento de embarazo de bajo riesgo en el Área Sanitaria V del Principado de Asturias / Low risk pregnancy control in the Health Area V-Asturias

Objetivo: Analizar el nivel de eficiencia del cambio en el protocolo de seguimiento de embarazo de bajo riesgo, desarrollado e implantado en atención primaria y atención hospitalizada. Metodología: Se calcula el coste económico teórico y real del seguimiento del embarazo de bajo riesgo desde febrero hasta julio de los años 2016 y 2017. Se comparan ambos costes y se calcula el ahorro teórico y real. El nuevo protocolo supone principalmente un cambio en la distribución de visitas entre el hospital, realizadas por obstetras, y la atención primaria, realizadas por matronas. La evaluación se hace en función del ahorro económico teórico previsto por la implantación del protocolo y el ahorro real generado durante el periodo de febrero-julio de 2017, según las tarifas de consultas publicadas en el Boletín Oficial del Principado de Asturias. Resultados: Disminución de un 75% de las consultas en el hospital antes de la semana 37 de gestación y un aumento del 100% en atención primaria. Dado el número de embarazos desde febrero hasta julio de los años 2016 y 2017, el ahorro teórico estimado es de 175.456,4 Euros, y el ahorro real de 20.007,2 Euros. Discusión: El análisis entre la situación teórica y la real muestra un alto número de consultas en atención primaria, una disminución menor de la esperada en las consultas de atención especializada y un inexplicable aumento de las consultas de embarazo de alto riesgo. Conclusiones: Es preciso realizar una revaluación una vez pasado el periodo de implantación, reconducir a atención primaria los controles de embarazo de bajo riesgo que siguen realizándose en el hospital, revisar el registro de visitas en atención primaria y evaluar el aumento de las consultas de embarazo de alto riesgo

Objective: The objective of this work is to analyze the efficiency level of the change in the protocol of low risk pregnancy, monitored, developed and implanted in primary care and hospitalized care. Methodology: The theoretical and real economic costs of monitoring low-risk pregnancy from February to July of 2016 and 2017 are calculated. Then, both costs are compared and finally, the theoretical and real savings are calculated. Mainly, the new protocol involves a change in the distribution of visits between hospitals made by obstetricians, and primary care, performed by midwives. The evaluation is based on the theoretical economic savings foreseen by the implementation of the protocol and the real savings generated during the period of February-July 2017, according to the consultation rates published in the Official Gazette of the Principado of Asturias. Results: Reduction of 75% of consultations in hospital before week 37 and a 100% increase in primary. Given the number of pregnancies of the period February-July 2016 and 2017, the estimated theoretical saving is 175.456.4 Euros and the real saving is 20.007.2 Euros. Discussion: The analysis between the theoretical situation and the real one reveals a high number of consultations in primary care, a smaller decrease, than expected, in specialized care consultations and an inexplicable increase in high risk pregnancy consultations. Conclusions: It is precise reassessment once the implementation period has passed, redirect to primary care those low risk pregnancy controls that continue to be performed in the hospital, review the registry of visits in primary care, and evaluate the increase in high-risk pregnancy consultations

Cost-benefit of hospitalization compared with outpatient care for pregnant women with pregestational and gestational diabetes or with mild hyperglycemia, in Brazil / Custo-benefício da hospitalização comparada ao atendimento ambulatorial em gestantes com diabetes pré-gestacional e gestacional ou com hiperglicemia leve, no Brasil

CONTEXT AND OBJECTIVE: Pregnancies complicated by diabetes are associated with increased numbers of maternal and neonatal complications. Hospital costs increase according to the type of care provided. This study aimed to estimate the cost-benefit relationship and social profitability ratio of hospitalization, compared with outpatient care, for pregnant women with diabetes or mild hyperglycemia. STUDY DESIGN: This was a prospective observational quantitative study conducted at a university hospital. It included all pregnant women with pregestational or gestational diabetes, or mild hyperglycemia, who did not develop clinical intercurrences during pregnancy and who delivered at the Botucatu Medical School Hospital (Hospital das Clínicas, Faculdade de Medicina de Botucatu, HC-FMB) of Universidade Estadual de São Paulo (Unesp). METHODS: Thirty pregnant women treated with diet were followed as outpatients, and twenty treated with diet plus insulin were managed through frequent short hospitalizations. Direct costs (personnel, materials and tests) and indirect costs (general expenses) were ascertained from data in the patients' records and the hospital's absorption costing system. The cost-benefit was then calculated. RESULTS: Successful treatment of pregnant women with diabetes avoided expenditure of US$ 1,517.97 and US$ 1,127.43 for patients treated with inpatient and outpatient care, respectively. The cost-benefit of inpatient care was US$ 143,719.16, and outpatient care, US$ 253,267.22, with social profitability of 1.87 and 5.35, respectively. CONCLUSION: Decision-tree analysis confirmed that successful treatment avoided costs at the hospital. Cost-benefit analysis showed that outpatient management was economically more advantageous than hospitalization. The social profitability of both treatments was greater than one, thus demonstrating that both types of care for diabetic pregnant women had positive benefits.

CONTEXTO E OBJETIVO: Gestações complicadas pelo diabetes estão associadas com aumento de complicações maternas e neonatais. Os custos hospitalares aumentam de acordo com a assistência prestada. O objetivo foi calcular o custo-benefício e a taxa de rentabilidade social da hospitalização comparada ao atendimento ambulatorial em gestantes com diabetes ou com hiperglicemia leve. DESENHO DO ESTUDO: Estudo prospectivo, observacional, quantitativo, realizado em hospital universitário, sendo incluídas todas as gestantes com diabetes pregestacional e gestacional ou com hiperglicemia leve que não desenvolveram intercorrências clínicas na gestação e que tiveram parto no Hospital das Clínicas, Faculdade de Medicina de Botucatu, Universidade Estadual Paulista (HC-FMB-Unesp). MÉTODOS: Trinta gestantes tratadas com dieta foram acompanhadas em ambulatório e 20 tratadas com dieta e insulina foram abordadas com hospitalizações curtas e frequentes. Foram obtidos custos diretos (pessoal, material e exames) e indiretos (despesas gerais) a partir de dados contidos no prontuário e no sistema de custo por absorção do hospital e posteriormente calculado o custo-benefício. RESULTADOS: O sucesso do tratamento das gestantes diabéticas evitou o gasto de US$ 1.517,97 e US$ 1.127,43 para pacientes hospitalizadas e ambulatoriais, respectivamente. O custo-benefício da atenção hospitalizada foi US$ 143.719,16 e ambulatorial, US$ 253.267,22, com rentabilidade social 1,87 e 5,35 respectivamente. CONCLUSÃO: A análise "árvore de decisão" confirma que o sucesso dos tratamentos elimina custos no hospital. A relação custo-benefício indicou que o tratamento ambulatorial é economicamente mais vantajoso do que a hospitalização. A rentabilidade social de ambos os tratamentos foi maior que 1, indicando que ambos os tipos de atendimento à gestante diabética têm benefício positivo.

Care cost for pregnant and parturient women with diabetes and mild hyperglycemia / Custo da assistência de gestantes e parturientes diabéticas e com hiperglicemia leve / Costo de la asistencia de gestantes y parturientas diabéticas y con hiperglicemia leve

OBJECTIVE: To compare inpatient and outpatient care costs for pregnant/parturient women with diabetes and mild hyperglycemia. METHODS: A prospective observational quantitative study was conducted in the Perinatal Diabetes Center in the city of Botucatu, Southeastern Brazil, between 2007 and 2008. Direct and indirect costs and disease-specific costs (medications and tests) were estimated. Thirty diet-treated pregnant women with diabetes were followed up on an outpatient basis, and 20 who required insulin therapy were hospitalized. RESULTS: The cost of diabetes disease (prenatal and delivery care) was US$ 3,311.84 for inpatients and US$ 1,366.04 for outpatients. CONCLUSIONS: Direct and indirect costs as well as total prenatal care cost were higher for diabetic inpatients while delivery care costs and delivery-postpartum hospitalization were similar. Prenatal and delivery-postpartum care costs were higher for these patients compared to those paid by Brazilian National Health System.

OBJETIVO: Comparar custos de hospitalização e de atenção ambulatorial em gestantes/parturientes diabéticas e com hiperglicemia leve. MÉTODOS: Estudo observacional, prospectivo, quantitativo descritivo realizado em centro de diabete perinatal em Botucatu, SP, entre 2007 e 2008. Foram estimados os custos por absorção diretos e indiretos disponíveis na instituição e os custos específicos para a doença (medicamentos e exames). As 30 gestantes diabéticas tratadas com dieta foram acompanhadas em ambulatório e 20 tratadas com dieta mais insulina foram hospitalizadas. RESULTADOS: O custo da doença diabete (para a assistência pré-natal e parto) foi de US$ 3,311.84 para as gestantes hospitalizadas e de US$ 1,366.04 para as acompanhadas em ambulatório. CONCLUSÕES: Os custos diretos e indiretos e o custo total da assistência pré-natal foram mais elevados nas gestantes diabéticas hospitalizadas enquanto os custos da assistência ao parto e hospitalização para parto e puerpério foram semelhantes. Os custos da assistência pré-natal como no parto/puerpério foram superiores aos valores pagos pelo Sistema Único de Saúde.

OBJETIVO: Comparar costos de hospitalización y de atención por ambulatorio en gestantes/parturientas diabéticas y con hiperglicemia leve. MÉTODOS: Estudio observacional, prospectivo, cuantitativo descriptivo realizado en centro de diabetes perinatal en Botucatu, Sureste de Brasil, entre 2007 y 2008. Se estimaron los costos por absorción directos e indirectos disponibles en la institución y los costos específicos para la enfermedad (medicamentos y exámenes). Las 30 gestantes diabéticas tratadas con dieta fueron acompañadas en ambulatorio y 20 tratadas con dieta más insulina fueron hospitalizadas. RESULTADOS: El costo de la enfermedad diabetes (para asistencia prenatal y parto) fue de US$ 3,311.84 para las gestantes hospitalizadas y de US$ 1,366.04 para las acompañadas en ambulatorio. CONCLUSIONES: Los costos directos e indirectos y el costo total de la asistencia prenatal fueron más elevados en las gestantes diabéticas hospitalizadas mientras que los costos de la asistencia al parto y hospitalización para parto y puerperio fueron semejantes. Los costos de la asistencia prenatal como en el parto/puerperio fueron superiores a los valores pagados por el Sistema Único de Salud.

Una propuesta metodológica para la apropiación de costos de producción en la atención prenatal / Methodology for appropriation of production costs in the primary prenatal care

La actual coyuntura económica brasileña trae consecuencias para el Estado en todas sus esferas, implicando en una cuidadosa planificación de sus administradores. Así, la aplicación adecuada de su presupuesto es uno de los objetivos primordiales anhelado por el sector salud. El presente estudio presentará una metodología para la apropiación de costos de la atención prenatal de bajo riesgo, que puede servir de subsidio para investigaciones científicas e intervención en la planificación y evaluación de costos. Esta apropiación se realizó teniendo como escenario la Salud de la Familia, al cual acuden las embarazadas de forma prioritaria. En la perspectiva de la cobertura universal a la que se propone el Sistema Único de Salud (SUS), el correcto estimado de los costos hará posible la contribución en la formulación presupuestaria y en la programación de recursos para garantizar una atención de calidad.

Brazilian economy nowadays shows that what is most important is for every sector to carefully plan, instead of merely spending finite financial resources. Thus, the adequate application of each health budget item has been one of the main goals of health planners and managers. This study aims to present a methodology for the appropriation of production costs in health care to low-risk pregnant women. It also intends to give the basis to the construction of a cost-evaluation methodology that can be used for both research and health planning. This appropriation was based on the scenario of the Family Health in São Paulo, Brazil. As the Brazilian Unified Health System has a universal covering perspective, the accurate estimate of production costs can contribute to the budget formulation and to the resources programming which seems essential to guarantee the quality of health assistance.

Una propuesta metodológica para la apropiación de costos de producción en la atención prenatal / /Methodology for appropriation of production costs in the primary prenatal care

La actual coyuntura económica brasileña trae consecuencias para el Estado en todas sus esferas, implicando en una cuidadosa planificación de sus administradores. Así, la aplicación adecuada de su presupuesto es uno de los objetivos primordiales anhelado por el sector salud. El presente estudio presentará una metodología para la apropiación de costos de la atención prenatal de bajo riesgo, que puede servir de subsidio para investigaciones científicas e intervención en la planificación y evaluación de costos. Esta apropiación se realizó teniendo como escenario la Salud de la Familia, al cual acuden las embarazadas de forma prioritaria. En la perspectiva de la cobertura universal a la que se propone el Sistema Único de Salud (SUS), el correcto estimado de los costos hará posible la contribución en la formulación presupuestaria y en la programación de recursos para garantizar una atención de calidad.(AU)

Brazilian economy nowadays shows that what is most important is for every sector to carefully plan, instead of merely spending finite financial resources. Thus, the adequate application of each health budget item has been one of the main goals of health planners and managers. This study aims to present a methodology for the appropriation of production costs in health care to low-risk pregnant women. It also intends to give the basis to the construction of a cost-evaluation methodology that can be used for both research and health planning. This appropriation was based on the scenario of the Family Health in São Paulo, Brazil. As the Brazilian Unified Health System has a universal covering perspective, the accurate estimate of production costs can contribute to the budget formulation and to the resources programming which seems essential to guarantee the quality of health assistance.(AU)

Costo oportunidad en la embarazada que demanda atención en primer nivel de atención / Cost opportunity in pregnant women who receive first-level of health care

Objetivo: Determinar el costo oportunidad de la embarazada que demanda atención en primer nivel de atención. Método: Estudio de costo oportunidad en la embarazada atendida en consulta de Medicina Familiar, Laboratorio y Farmacia, que acudieron solas o acompañadas a 3 unidades de Medicina Familiar. Se estudiaron 807 embarazadas. La técnica muestral contempló conglomerados (Unidad Médica), estratos (consultorio) y al interior por cuota. Se estudió edad, estado civil, ocupación y número de acompañantes. El costo oportunidad se evaluó a través de tiempo invertido y el costo por minuto; se estimó para el traslado, espera y atención en los tres servicios señalados, para la paciente y acompañante. Se utilizó porcentajes, promedios e intervalos de confianza del 95 por ciento. Resultados: El costo oportunidad de la embarazada sola en consulta de Medicina Familiar es $46,48 (IC95 por ciento 41,68-51,27), del acompañante 1 $49,91 (IC 95 por ciento 41,49-58,39) y acompañante 2 $9,84 (IC95 por ciento 4,05-15,99); cuando la embarazada acude con un acompañante el costo oportunidad es de $95,62 y con dos acompañantes $106,23. El costo oportunidad de la embarazada sola en Farmacia es $22,14 y en Laboratorio $34,82. El costo oportunidad ajustado por número de acompañantes en consulta de Medicina Familiar es $77,14; si utiliza en la misma visita la consulta de Medicina Familiar, Laboratorio y Farmacia es de $104,20. Conclusión: El costo oportunidad en la paciente embarazada que demanda atención en primer nivel tiene variaciones importantes determinadas por el número de servicios que utilice y la presencia de acompañantes.

Objective: To determine the cost opportunity for pregnant women who receive first-level health care. Methods. Cost opportunity study including 807 pregnant tamales who received first-level care in the family medicine, laboratory and pharmacy areas. The sample was distributed by medical unit and stratified by office. Variables included age, marital status, occupation, number of accompanying; cost opportunity was estimated for transfers, waiting and care time in the mentioned service areas. Cost opportunity was calculated for the patient and for those persons who accompanied the patient and included the time invested and cost per minute. Statistical analysis included averages and 95 percent confidence intervals. Results. Cost opportunity for pregnant alone in family medicine is $46.48 (IC 95 percent 41.68-51.27), companion 1 $49.91 (IC 95 percent 41.49-58.39) and companion 2 $9.84 (IC 95 percent 4.05-15.99); for pregnant women and one companion, cost opportunity is $95.62 and whit two companions $106.23. Cost opportunity for pregnant women alone in pharmacy is $22.14 and laboratory $34.82. Cost opportunity adjusted by companions in family medicine is $77.14, if used in the same visit family medicine, laboratory and pharmacy is $104.20. Conclusion. Cost opportunity for a pregnant woman who receives first-level care it has significant variations determined by the number of services that use and the presence of companions.